AbbVie’s Vraylar wins approval as adjunctive therapy for depression Posted on December 16, 2022 By Charlielikes Stock Market Tags:– as, abbvie’s, adjunctive, approval, depression, for, market, stock, stock market, therapy, vraylar, wins